Literature DB >> 389158

Netilmicin treatment of complicated urinary tract infection in patients with renal function impairment.

N Frimodt-Möller, S Maigaard, P O Madsen.   

Abstract

The efficacy and tolerance of netilmicin was studied in 28 elderly male patients with varying degrees of renal function impairment who suffered from complicated urinary tract infections. Doses of netilmicin, equivalent to 2 mg/kg divided by milligrams of creatinine per 100 ml, were administered every 12 h. A 62% cure rate, defined as negative urine culture at 1-week follow-up, was obtained. Treatment failure correlated with impaired renal function. Nephrotoxic reaction, defined as any significant increase in serum creatinine during treatment, was found in 6 of 28 patients (21%). The increase in serum creatinine was transient in all except one of these patients. Apart from the finding of a significant correlation between nephrotoxic reaction to netilmicin and postoperative urinary tract infection, no clinical or therapeutic features correlated with nephrotoxicity; trough concentrations correlated with serum creatinine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389158      PMCID: PMC352868          DOI: 10.1128/AAC.16.3.406

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Renal function after major surgery assessed on the basis of the 24-hour creatinine clearance.

Authors:  E KRAGELUND
Journal:  Acta Chir Scand       Date:  1959-09-20

2.  Netilmicin pharmacokinetics after single intravenous doses to elderly male patients.

Authors:  P G Welling; A Baumueller; C C Lau; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

3.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

5.  Drug dosage in patients with impaired renal function.

Authors:  L Dettli; P Spring; R Habersang
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

6.  Gentamicin therapy in renal failure: a nomogram for dosage.

Authors:  R A Chan; E J Benner; P D Hoeprich
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

7.  Comparative nephrotoxicities of netilmicin and gentamicin in rats.

Authors:  F C Luft; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

8.  Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections.

Authors:  S Maigaard; N Frimodt-Möller; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

9.  Pharmacology and efficacy of netilmicin.

Authors:  I Trestman; J Parsons; J Santoro; G Goodhart; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

10.  Gentamicin tissue accumulation and nephrotoxic reactions.

Authors:  J J Schentag; T J Cumbo; W J Jusko; M E Plaut
Journal:  JAMA       Date:  1978-11-03       Impact factor: 56.272

View more
  3 in total

1.  Single-dose treatment with netilmicin for different clinical forms of urinary tract infections.

Authors:  V Prát; M Horcicková; M Hatala; K Matousovic; M Liska; J Hnátek; Z Milotová
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

Review 2.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

3.  Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.

Authors:  J M Gatell; J G SanMiguel; V Araujo; L Zamora; J Maña; M Ferrer; M Bonet; M Bohe; M T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.